Pieter Sinonquel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pieter Sinonquel has a total of 193 co-authors. Here are the top co-authors by number of shared publications:
- Raf Bisschops
University Hospitals Leuven, KU Leuven, Belgium
16 shared publications - Bram Verstockt
Department of Gastroenterology and Hepatology University Hospitals Leuven KU Leuven Leuven Belgium
7 shared publications - Peter Bossuyt
Imelda GI Clinical Research Centre, Bonheiden, Belgium
6 shared publications - Cesare Hassan
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy
5 shared publications - Frederik Maes
KU Leuven
5 shared publications - Tom Eelbode
Department of Electrical Engineering (ESAT/PSI), Medical Imaging Research Center, KU Leuven, Leuven, Belgium
5 shared publications
Latest Publications
- 20 March 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (04) , 437
Reply to Lei et al.
10.1055/a-2776-5205 We thank Lei et al. [1] for their constructive correspondence regarding our recently published European Society of Gastrointestinal Endoscopy (ESGE) position statement. The goal of our statement is to facilitate the safe and effective integration of artificial intelligence (AI) tools into endoscopy training [2]. We appreciate the points raised, particularly concerning the importance of the timing of AI introduction during training and the need for bias-mitigation measures. In terms of timing, we fully agree that further research is required to determine the optimal timing for the introduction of AI in endoscopy training. The current lack of robust evidence limited our position statement to raising awareness of AI-related bias. Nevertheless, future revisions should expand guidance on when and how AI tools should be incorporated into training curricula, supported by stronger research-based evidence. We also agree with the insights regarding bias mitigation. The introduction of AI should be approached with a balanced perspective, rather than being dominated by concerns related to AI-driven bias, such as automation bias or deskilling [3]. Human progress has historically involved both gains and losses; for example, while calculators save time and enable focus on higher level tasks, they may also erode our calculation skills. Such trade-offs are usually regarded as a positive aspect of human evolution. Similarly, in medicine, the thoughtful integration of AI may allow clinicians to focus more on aspects of patient care that are of greater importance, representing a technological benefit. On the other hand, it remains essential to investigate strategies to mitigate bias and safeguard our life-critical clinical skills, such as resuscitation techniques. Potential approaches include simulation-based training, as highlighted by the authors, as well as psychological interventions addressing human behavior [4]. In conclusion, these issues are central to the safe integration of AI into endoscopy training and should be addressed in future evidence-based curricula. Article published online: 20 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 20 March 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (04) , 437
Reply to Lei et al.
10.1055/a-2776-5205 We thank Lei et al. [1] for their constructive correspondence regarding our recently published European Society of Gastrointestinal Endoscopy (ESGE) position statement. The goal of our statement is to facilitate the safe and effective integration of artificial intelligence (AI) tools into endoscopy training [2]. We appreciate the points raised, particularly concerning the importance of the timing of AI introduction during training and the need for bias-mitigation measures. In terms of timing, we fully agree that further research is required to determine the optimal timing for the introduction of AI in endoscopy training. The current lack of robust evidence limited our position statement to raising awareness of AI-related bias. Nevertheless, future revisions should expand guidance on when and how AI tools should be incorporated into training curricula, supported by stronger research-based evidence. We also agree with the insights regarding bias mitigation. The introduction of AI should be approached with a balanced perspective, rather than being dominated by concerns related to AI-driven bias, such as automation bias or deskilling [3]. Human progress has historically involved both gains and losses; for example, while calculators save time and enable focus on higher level tasks, they may also erode our calculation skills. Such trade-offs are usually regarded as a positive aspect of human evolution. Similarly, in medicine, the thoughtful integration of AI may allow clinicians to focus more on aspects of patient care that are of greater importance, representing a technological benefit. On the other hand, it remains essential to investigate strategies to mitigate bias and safeguard our life-critical clinical skills, such as resuscitation techniques. Potential approaches include simulation-based training, as highlighted by the authors, as well as psychological interventions addressing human behavior [4]. In conclusion, these issues are central to the safe integration of AI into endoscopy training and should be addressed in future evidence-based curricula. Article published online: 20 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 17 October 2025
- Published by Georg Thieme Verlag KG in Endoscopy
Long-term learning and not deskilling: a reassuring signal for computer-aided detection-assisted colonoscopy
10.1055/a-2661-2624 In the rapidly evolving field of gastrointestinal endoscopy, the integration of artificial intelligence (AI), particularly computer-aided detection (CADe), has shown promise in enhancing the adenoma detection rate (ADR), one of the key quality indicators of screening colonoscopy [1] [2] [3]. Yet, as enthusiasm for AI grows, so do the concerns about its unintended consequences. Foremost among these is the possibility of “deskilling,” a phenomenon in which over-reliance on AI, referred to as automation bias, might erode an endoscopist’s diagnostic and even technical performance over time. To address this unexplored backdrop, the prospective observational study by Okumura et al. [4] offers a reassuring and well-described perspective on what the impact of CADe may be on endoscopists’ learning curves. The authors investigated, for the first time, the long-term evolution of the ADR among endoscopists exposed to CADe. With over 4700 propensity score-matched colonoscopy cases and follow-up for 3 years, the authors evaluated performance trends using cumulative summation analysis, a robust and objective tool to monitor real-time skill acquisition and retention, which is independent of sample size. Their conclusions are both lucid and important: their study did not reveal any evidence of deterioration in ADR in procedures performed without CADe after its introduction into clinical practice. This directly challenges the hypothesis that CADe leads to deskilling over time. In contrast, high detecting endoscopists (baseline ADR ≥25%) achieved accelerated learning curves and sustained improvements in non-CADe procedures, suggesting that the exposure to AI support helped in improving already established detection strategies, for both adenomas and sessile serrated lesions. These findings were also supported by a recent nonrandomized controlled trial using CADe monitored by a second observer, which demonstrated a significant benefit of CADe for detectors with ADRs of 20%–40% [5]. The true long-term effect of CADe on endoscopy skills however was not evaluated in this study. The favorable outcome reported by Okumura et al. contrasts with the conclusions of a recent multicenter observational study by Budzyń et al., which raised significant concerns about performance regression in non-CADe settings [6]. In their multicenter analysis, the authors reported a decrease in ADR after CADe withdrawal, especially among less experienced endoscopists, prompting the suggestion that AI may inhibit long-term skill development. In contrast, Okumura et al. used a pragmatic single-center design and carefully categorized endoscopists by their baseline detection performance, not simply by procedural experience. This classification revealed an important nuance: while high detectors improved with and without CADe, low detectors (ADR <25%) did not show significant improved learning effects, even after extended CADe exposure. However, and even more crucially, their performance did not decline either. This results in a two-fold implication. First, CADe can serve as a learning adjunct for proficient endoscopists, with benefits that persist beyond the presence of the tool itself. Second, poorer performing endoscopists may require additional structured feedback or targeted educational strategies to fully benefit from CADe support. Therefore, the AI system alone may be insufficient to uniformly enhance skills across all users, analogous to how a GPS can chart optimal directions, but only if the driver has the ability to drive the car. This differentiation echoes prior findings suggesting that baseline ADR, rather than total procedural volume, may be a more reliable indicator of an endoscopist’s potential to internalize and apply detection techniques [7]. The study of Okumura et al. supports this notion, indicating that personality traits such as vigilance and attention to detail, or technical experience, which may be more prevalent among high detectors, could influence the effectiveness of CADe for long-term skills improvement. Another important strength of the authors’ study lies in its real-world longitudinal design. In contrast to randomized trials, which are susceptible to the potential Hawthorne effect where participants may alter their behavior owing to their awareness of being observed, the observational design of this study is more likely to accurately capture routine clinical practice. By incorporating CADe into daily practice and analyzing performance across both CADe and non-CADe cases, the authors mimic the actual variability of modern endoscopy units where AI tools are often selectively deployed. Again, this underscores a few substantial implications. First, these findings reframe the current conversation around AI in colonoscopy, which is focused on the short-term efficacy and the fear of overdependence, to one that considers a sustained skill development and performance reinforcement in already skilled endoscopists but also keeps lower detectors from ultimate deskilling. Second, they offer reassurance to international guideline organizations and training institutions that CADe does not need to be seen as a jeopardy to clinical competence, provided its implementation is thoughtful and monitored, and on condition that the current observational findings can be reproduced in consecutive multicenter trials. Finally, the study results highlight the need for personalized AI-assisted training programs, particularly to address the learning needs of low detectors. As the authors appropriately acknowledge, certain limitations persist. First and foremost, this was a single-center study, and the endoscopists included were not categorized as beginners, a group for whom skill retention is crucial. Second, despite the rigorous methodology, the study team also included CADe system developers, raising the potential for developer bias. Despite this, the...
- 17 October 2025
- Published by Georg Thieme Verlag KG in Endoscopy
Long-term learning and not deskilling: a reassuring signal for computer-aided detection-assisted colonoscopy
10.1055/a-2661-2624 In the rapidly evolving field of gastrointestinal endoscopy, the integration of artificial intelligence (AI), particularly computer-aided detection (CADe), has shown promise in enhancing the adenoma detection rate (ADR), one of the key quality indicators of screening colonoscopy [1] [2] [3]. Yet, as enthusiasm for AI grows, so do the concerns about its unintended consequences. Foremost among these is the possibility of “deskilling,” a phenomenon in which over-reliance on AI, referred to as automation bias, might erode an endoscopist’s diagnostic and even technical performance over time. To address this unexplored backdrop, the prospective observational study by Okumura et al. [4] offers a reassuring and well-described perspective on what the impact of CADe may be on endoscopists’ learning curves. The authors investigated, for the first time, the long-term evolution of the ADR among endoscopists exposed to CADe. With over 4700 propensity score-matched colonoscopy cases and follow-up for 3 years, the authors evaluated performance trends using cumulative summation analysis, a robust and objective tool to monitor real-time skill acquisition and retention, which is independent of sample size. Their conclusions are both lucid and important: their study did not reveal any evidence of deterioration in ADR in procedures performed without CADe after its introduction into clinical practice. This directly challenges the hypothesis that CADe leads to deskilling over time. In contrast, high detecting endoscopists (baseline ADR ≥25%) achieved accelerated learning curves and sustained improvements in non-CADe procedures, suggesting that the exposure to AI support helped in improving already established detection strategies, for both adenomas and sessile serrated lesions. These findings were also supported by a recent nonrandomized controlled trial using CADe monitored by a second observer, which demonstrated a significant benefit of CADe for detectors with ADRs of 20%–40% [5]. The true long-term effect of CADe on endoscopy skills however was not evaluated in this study. The favorable outcome reported by Okumura et al. contrasts with the conclusions of a recent multicenter observational study by Budzyń et al., which raised significant concerns about performance regression in non-CADe settings [6]. In their multicenter analysis, the authors reported a decrease in ADR after CADe withdrawal, especially among less experienced endoscopists, prompting the suggestion that AI may inhibit long-term skill development. In contrast, Okumura et al. used a pragmatic single-center design and carefully categorized endoscopists by their baseline detection performance, not simply by procedural experience. This classification revealed an important nuance: while high detectors improved with and without CADe, low detectors (ADR <25%) did not show significant improved learning effects, even after extended CADe exposure. However, and even more crucially, their performance did not decline either. This results in a two-fold implication. First, CADe can serve as a learning adjunct for proficient endoscopists, with benefits that persist beyond the presence of the tool itself. Second, poorer performing endoscopists may require additional structured feedback or targeted educational strategies to fully benefit from CADe support. Therefore, the AI system alone may be insufficient to uniformly enhance skills across all users, analogous to how a GPS can chart optimal directions, but only if the driver has the ability to drive the car. This differentiation echoes prior findings suggesting that baseline ADR, rather than total procedural volume, may be a more reliable indicator of an endoscopist’s potential to internalize and apply detection techniques [7]. The study of Okumura et al. supports this notion, indicating that personality traits such as vigilance and attention to detail, or technical experience, which may be more prevalent among high detectors, could influence the effectiveness of CADe for long-term skills improvement. Another important strength of the authors’ study lies in its real-world longitudinal design. In contrast to randomized trials, which are susceptible to the potential Hawthorne effect where participants may alter their behavior owing to their awareness of being observed, the observational design of this study is more likely to accurately capture routine clinical practice. By incorporating CADe into daily practice and analyzing performance across both CADe and non-CADe cases, the authors mimic the actual variability of modern endoscopy units where AI tools are often selectively deployed. Again, this underscores a few substantial implications. First, these findings reframe the current conversation around AI in colonoscopy, which is focused on the short-term efficacy and the fear of overdependence, to one that considers a sustained skill development and performance reinforcement in already skilled endoscopists but also keeps lower detectors from ultimate deskilling. Second, they offer reassurance to international guideline organizations and training institutions that CADe does not need to be seen as a jeopardy to clinical competence, provided its implementation is thoughtful and monitored, and on condition that the current observational findings can be reproduced in consecutive multicenter trials. Finally, the study results highlight the need for personalized AI-assisted training programs, particularly to address the learning needs of low detectors. As the authors appropriately acknowledge, certain limitations persist. First and foremost, this was a single-center study, and the endoscopists included were not categorized as beginners, a group for whom skill retention is crucial. Second, despite the rigorous methodology, the study team also included CADe system developers, raising the potential for developer bias. Despite this, the...
- 12 August 2025
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (4)
Results of the Ninth Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): artificial intelligence in IBD: regulatory and methodological considerations
With the rapid growth of artificial intelligence (AI) applications in the field of inflammatory bowel disease (IBD), an increasing number of regulatory and methodological considerations have become apparent. Currently, there remains much uncertainty and limited experience in the field of IBD regarding some of the regulatory and methodological pitfalls to be considered when developing and deploying AI applications for positive clinical and health system impact. Accordingly, an expert panel was convened by the European Crohn’s and Colitis Organisation to review the published literature and provide an overview of key regulatory aspects for the application of AI in IBD. This article discusses and, where possible, provides guidance on key methodological and regulatory considerations for AI in IBD. Topics covered include: potential clinical application-focused algorithm design; ethical, moral and legal considerations; regulatory agency perspectives; an overview of regulatory submission and consideration of reimbursement. By providing clinicians with a primer to key regulatory and methodological considerations, we hope to accelerate knowledge translation and implementation of AI-enabled digital health innovations in clinical practice and ultimately improve outcomes for people living with and caring for those living with IBD.
- 12 August 2025
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (4)
Results of the Ninth Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): artificial intelligence in IBD: regulatory and methodological considerations
With the rapid growth of artificial intelligence (AI) applications in the field of inflammatory bowel disease (IBD), an increasing number of regulatory and methodological considerations have become apparent. Currently, there remains much uncertainty and limited experience in the field of IBD regarding some of the regulatory and methodological pitfalls to be considered when developing and deploying AI applications for positive clinical and health system impact. Accordingly, an expert panel was convened by the European Crohn’s and Colitis Organisation to review the published literature and provide an overview of key regulatory aspects for the application of AI in IBD. This article discusses and, where possible, provides guidance on key methodological and regulatory considerations for AI in IBD. Topics covered include: potential clinical application-focused algorithm design; ethical, moral and legal considerations; regulatory agency perspectives; an overview of regulatory submission and consideration of reimbursement. By providing clinicians with a primer to key regulatory and methodological considerations, we hope to accelerate knowledge translation and implementation of AI-enabled digital health innovations in clinical practice and ultimately improve outcomes for people living with and caring for those living with IBD.
- 12 August 2025
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (4)
Results of the Ninth Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicine
Background and Aims: Artificial intelligence (AI) is increasingly being applied in various fields of medicine, including inflammatory bowel diseases (IBD). This systematic review, conducted as part of the ECCO 9th Scientific Workshop on AI in IBD, explores AI applications in multiomics precision medicine, large language models (LLMs) for textual tasks, and utilization of wearable and remote care technologies. Methods: A comprehensive systematic analysis of the literature was undertaken, emphasizing three topics: multiomics predictive models in IBD; natural language processing (NLP) and LLMs for clinical practice, research and patient communication; and the role of remote monitoring and wearable devices. Results: Key areas of promise include the implementation of NLP and LLMs for case identification and differentiation, tracking disease activity, pharmacovigilance, quality assurance, and patient support. Multiomic approaches, integrating genomics, transcriptomics, proteomics, metabolomics, and metagenomics, show potential for developing more accurate diagnostic and risk prediction models and improving treatment response prediction and detection of actionable drug targets for future therapeutics. Wearables and remote monitoring technologies can transform IBD management from episodic assessments to continuous, less biased tracking of patient-reported outcomes and physiological biomarkers. Conclusions: While AI and multiomics approaches hold substantial promise for advancing IBD management and research, further refinement is necessary to ensure content validity and address safety concerns, thereby allowing integration of AI into clinical workflows and safeguarding of data privacy. Future research should prioritize the integration of diverse omic data, conduct of longitudinal studies, and validation in large and diverse cohorts.
- 12 August 2025
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (4)
Results of the Ninth Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicine
Background and Aims: Artificial intelligence (AI) is increasingly being applied in various fields of medicine, including inflammatory bowel diseases (IBD). This systematic review, conducted as part of the ECCO 9th Scientific Workshop on AI in IBD, explores AI applications in multiomics precision medicine, large language models (LLMs) for textual tasks, and utilization of wearable and remote care technologies. Methods: A comprehensive systematic analysis of the literature was undertaken, emphasizing three topics: multiomics predictive models in IBD; natural language processing (NLP) and LLMs for clinical practice, research and patient communication; and the role of remote monitoring and wearable devices. Results: Key areas of promise include the implementation of NLP and LLMs for case identification and differentiation, tracking disease activity, pharmacovigilance, quality assurance, and patient support. Multiomic approaches, integrating genomics, transcriptomics, proteomics, metabolomics, and metagenomics, show potential for developing more accurate diagnostic and risk prediction models and improving treatment response prediction and detection of actionable drug targets for future therapeutics. Wearables and remote monitoring technologies can transform IBD management from episodic assessments to continuous, less biased tracking of patient-reported outcomes and physiological biomarkers. Conclusions: While AI and multiomics approaches hold substantial promise for advancing IBD management and research, further refinement is necessary to ensure content validity and address safety concerns, thereby allowing integration of AI into clinical workflows and safeguarding of data privacy. Future research should prioritize the integration of diverse omic data, conduct of longitudinal studies, and validation in large and diverse cohorts.
- 12 August 2025
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (4)
Results of the Ninth Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): artificial intelligence in endoscopy, radiology, and histology in inflammatory bowel disease diagnostics
In this review, a comprehensive overview of the current state of artificial intelligence (AI) research in inflammatory bowel disease (IBD) diagnostics in the domains of endoscopy, radiology, and histology is presented. Moreover, key considerations for the development of AI algorithms in medical image analysis are discussed. AI presents a potential breakthrough in real-time, objective, and rapid endoscopic assessment, with implications for predicting disease progression. It is anticipated that, by harmonizing multimodal data, AI will transform patient care through early diagnosis, accurate patient profiling, and therapeutic response prediction. The ability of AI in cross-sectional medical imaging to improve diagnostic accuracy, automate and enable objective assessment of disease activity, and predict clinical outcomes highlights its transformative potential. AI models have consistently outperformed traditional methods of image interpretation, particularly in complex areas such as differentiating IBD subtypes, identifying disease progression, and complications. The use of AI in histology is a particularly dynamic research field. Implementation of AI algorithms in clinical practice is still lagging, a major hurdle being the lack of a digital workflow in many pathology institutes. Adoption is likely to start with implementation of automatic disease activity scoring. Beyond matching pathologist performance, algorithms may teach us more about the pathophysiology of IBD. While AI is set to substantially advance IBD diagnostics, various challenges such as heterogeneous datasets, retrospective designs, and assessment of different endpoints must be addressed. Implementation of novel standards of reporting may drive an increase in research quality and overcome these obstacles.
- 12 August 2025
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (4)
Results of the Ninth Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): artificial intelligence in endoscopy, radiology, and histology in inflammatory bowel disease diagnostics
In this review, a comprehensive overview of the current state of artificial intelligence (AI) research in inflammatory bowel disease (IBD) diagnostics in the domains of endoscopy, radiology, and histology is presented. Moreover, key considerations for the development of AI algorithms in medical image analysis are discussed. AI presents a potential breakthrough in real-time, objective, and rapid endoscopic assessment, with implications for predicting disease progression. It is anticipated that, by harmonizing multimodal data, AI will transform patient care through early diagnosis, accurate patient profiling, and therapeutic response prediction. The ability of AI in cross-sectional medical imaging to improve diagnostic accuracy, automate and enable objective assessment of disease activity, and predict clinical outcomes highlights its transformative potential. AI models have consistently outperformed traditional methods of image interpretation, particularly in complex areas such as differentiating IBD subtypes, identifying disease progression, and complications. The use of AI in histology is a particularly dynamic research field. Implementation of AI algorithms in clinical practice is still lagging, a major hurdle being the lack of a digital workflow in many pathology institutes. Adoption is likely to start with implementation of automatic disease activity scoring. Beyond matching pathologist performance, algorithms may teach us more about the pathophysiology of IBD. While AI is set to substantially advance IBD diagnostics, various challenges such as heterogeneous datasets, retrospective designs, and assessment of different endpoints must be addressed. Implementation of novel standards of reporting may drive an increase in research quality and overcome these obstacles.
- 12 March 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (07) , 753-759
Real-time automated assessment of histological disease activity in patients with ulcerative colitis using single-wavelength endoscopy technology
Single-wavelength endoscopy (SWE) has shown promising results in assessing histological disease activity in ulcerative colitis. Our objective was to validate the real-time performance of a bedside prototype of SWE computer-aided diagnosis (CAD) as proof of concept.A bedside module for real-time use evaluated histological disease activity when endoscopy was performed in the rectum and sigmoid based on white-light endoscopy and SWE (410 nm monochromatic light). Biopsies were taken for reference and scored using the Geboes score (GBS). SWE-CAD displayed a blue or red indicator, corresponding to histological remission or non-remission, respectively. Simultaneous scoring using the Mayo Endoscopic Score was performed by the endoscopist.In 36 patients, histological disease activity was automatically scored using SWE-CAD. At the section level, SWE-CAD showed an accuracy of 96.4%, sensitivity of 96.1%, and specificity of 85.5%. When differentiating disease activity into mild, moderate, and severe, accuracy was 97.7%, 62.8%, and 95.0%, respectively. At the per-patient level, overall diagnostic accuracy remained high at 94.4%, with only 2/36 underestimations compared with GBS.A novel SWE-CAD system demonstrated clinical accuracy of 94.4% at the per-patient level, potentially aiding physicians in interpreting subtle endoscopic abnormalities and paving the way to more individualized patient management.
- 12 March 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (07) , 753-759
Real-time automated assessment of histological disease activity in patients with ulcerative colitis using single-wavelength endoscopy technology
Single-wavelength endoscopy (SWE) has shown promising results in assessing histological disease activity in ulcerative colitis. Our objective was to validate the real-time performance of a bedside prototype of SWE computer-aided diagnosis (CAD) as proof of concept.A bedside module for real-time use evaluated histological disease activity when endoscopy was performed in the rectum and sigmoid based on white-light endoscopy and SWE (410 nm monochromatic light). Biopsies were taken for reference and scored using the Geboes score (GBS). SWE-CAD displayed a blue or red indicator, corresponding to histological remission or non-remission, respectively. Simultaneous scoring using the Mayo Endoscopic Score was performed by the endoscopist.In 36 patients, histological disease activity was automatically scored using SWE-CAD. At the section level, SWE-CAD showed an accuracy of 96.4%, sensitivity of 96.1%, and specificity of 85.5%. When differentiating disease activity into mild, moderate, and severe, accuracy was 97.7%, 62.8%, and 95.0%, respectively. At the per-patient level, overall diagnostic accuracy remained high at 94.4%, with only 2/36 underestimations compared with GBS.A novel SWE-CAD system demonstrated clinical accuracy of 94.4% at the per-patient level, potentially aiding physicians in interpreting subtle endoscopic abnormalities and paving the way to more individualized patient management.
- 27 November 2024
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 19 (5)
Development of an Automated Tool for the Estimation of Histological Remission in Ulcerative Colitis Using Single-Wavelength Endoscopy Technology
Background and Aims: Ulcerative colitis (UC) management employs a strategy targeting histological and endoscopic remission. Correlation of white light endoscopy (WLE) scores with histological activity is limited. Single-wavelength endoscopy (SWE), addressing microvascular changes reflecting histological disease activity, may better assess histological remission. Our goal was to assess the accuracy of a computer-aided diagnosis (CAD) system for histological activity estimation in UC, based on either WLE or SWE. Methods: We collected 6926 sets of corresponding WLE and SWE frames in 112 patients with UC, using a prototype endoscopic system enabling both imaging methods (FUJIFILM, Tokyo, Japan). Histological remission (Geboes score ≤ 2B.0) assessed at the location of imaging was annotated for all frames, and separate WLE-CAD and SWE-CAD models were trained using deep learning for automated detection of histological remission with either imaging modality. Results: Initial training of both models on the same subset of 42 patients resulted in SWE-CAD outperforming WLE-CAD with a mean sensitivity of 88.0% vs 73.9% (p < 0.001), a mean specificity of 71.7% vs 65.6% (p = 0.45), and a diagnostic accuracy of 83.3% vs 67.5% (p < 0.005), respectively. Consecutive training of the SWE-CAD model on the entire dataset (112 patients) resulted in an accuracy of 95.2%, sensitivity of 96.4%, and specificity of 92.9% on a section level. Conclusions: By utilizing automated CAD based on non-magnifying SWE for enhanced capillary visibility vs WLE, histological remission was detected with 95.2% diagnostic accuracy in patients with UC, offering stable objectivity and helping to exclude inter-reader variability.
- 27 November 2024
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 19 (5)
Development of an Automated Tool for the Estimation of Histological Remission in Ulcerative Colitis Using Single-Wavelength Endoscopy Technology
Background and Aims: Ulcerative colitis (UC) management employs a strategy targeting histological and endoscopic remission. Correlation of white light endoscopy (WLE) scores with histological activity is limited. Single-wavelength endoscopy (SWE), addressing microvascular changes reflecting histological disease activity, may better assess histological remission. Our goal was to assess the accuracy of a computer-aided diagnosis (CAD) system for histological activity estimation in UC, based on either WLE or SWE. Methods: We collected 6926 sets of corresponding WLE and SWE frames in 112 patients with UC, using a prototype endoscopic system enabling both imaging methods (FUJIFILM, Tokyo, Japan). Histological remission (Geboes score ≤ 2B.0) assessed at the location of imaging was annotated for all frames, and separate WLE-CAD and SWE-CAD models were trained using deep learning for automated detection of histological remission with either imaging modality. Results: Initial training of both models on the same subset of 42 patients resulted in SWE-CAD outperforming WLE-CAD with a mean sensitivity of 88.0% vs 73.9% (p < 0.001), a mean specificity of 71.7% vs 65.6% (p = 0.45), and a diagnostic accuracy of 83.3% vs 67.5% (p < 0.005), respectively. Consecutive training of the SWE-CAD model on the entire dataset (112 patients) resulted in an accuracy of 95.2%, sensitivity of 96.4%, and specificity of 92.9% on a section level. Conclusions: By utilizing automated CAD based on non-magnifying SWE for enhanced capillary visibility vs WLE, histological remission was detected with 95.2% diagnostic accuracy in patients with UC, offering stable objectivity and helping to exclude inter-reader variability.
- Open Access
- 7 November 2024
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 12 (11) , E1386-E1391
Dye-based chromoendoscopy versus i-scan virtual chromoendoscopy in long-standing ulcerative colitis: Multicenter prospective RCT
Background and study aims Long-standing ulcerative colitis (UC) is associated with an increased risk of developing colorectal neoplasia. Both dye-based chromoendoscopy (DCE) and virtual chromoendoscopy (VCE) increase detection of neoplastic lesions. In this prospective randomized controlled trial (RCT), we compared the neoplasia detection rate between DCE and i-scan VCE in patients with long-standing UC. Patient and methods In four European hospitals, 131 patients with long-standing UC (disease duration > 8 years) were randomized to either DCE with methylene blue 0.1% (n = 66) or i-scan VCE (n = 65). All procedures were performed by trained endoscopists. Biopsies were taken from all visible lesions and the surrounding mucosa. Results The mean number of neoplastic lesions detected per colonoscopy was not significantly different between DCE (0.27) and i-scan VCE (0.37) (P = 0.41). Similarly, there was no significant difference in neoplasia detection rate between DCE (19.7%) and VCE (27.7%) (odds ratio0.64, 95% confidence interval 0.28–1.50, P = 0.31). However, the per lesion neoplasia detection rate was significantly higher with i-scan VCE compared to DCE (27.6% vs 15.3%, P = 0.036). Both withdrawal and total procedure time were on average 10.0 and 9.9 minutes shorter using i-scan VCE (both P < 0.001). Conclusions This multicenter, prospective RCT showed no significant difference in neoplasia detection between DCE and i-scan VCE in long-standing UC. However, use of i-scan VCE was associated with a lower false-positive rate and a significantly shorter procedure time compared with DCE. I-scan VCE, therefore, could be a valid replacement for DCE in UC surveillance colonoscopies.
- 7 November 2024
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 12 (11) , E1386-E1391
Open AccessDye-based chromoendoscopy versus i-scan virtual chromoendoscopy in long-standing ulcerative colitis: Multicenter prospective RCT
Background and study aims Long-standing ulcerative colitis (UC) is associated with an increased risk of developing colorectal neoplasia. Both dye-based chromoendoscopy (DCE) and virtual chromoendoscopy (VCE) increase detection of neoplastic lesions. In this prospective randomized controlled trial (RCT), we compared the neoplasia detection rate between DCE and i-scan VCE in patients with long-standing UC. Patient and methods In four European hospitals, 131 patients with long-standing UC (disease duration > 8 years) were randomized to either DCE with methylene blue 0.1% (n = 66) or i-scan VCE (n = 65). All procedures were performed by trained endoscopists. Biopsies were taken from all visible lesions and the surrounding mucosa. Results The mean number of neoplastic lesions detected per colonoscopy was not significantly different between DCE (0.27) and i-scan VCE (0.37) (P = 0.41). Similarly, there was no significant difference in neoplasia detection rate between DCE (19.7%) and VCE (27.7%) (odds ratio0.64, 95% confidence interval 0.28–1.50, P = 0.31). However, the per lesion neoplasia detection rate was significantly higher with i-scan VCE compared to DCE (27.6% vs 15.3%, P = 0.036). Both withdrawal and total procedure time were on average 10.0 and 9.9 minutes shorter using i-scan VCE (both P < 0.001). Conclusions This multicenter, prospective RCT showed no significant difference in neoplasia detection between DCE and i-scan VCE in long-standing UC. However, use of i-scan VCE was associated with a lower false-positive rate and a significantly shorter procedure time compared with DCE. I-scan VCE, therefore, could be a valid replacement for DCE in UC surveillance colonoscopies.
QUAIDE - Quality assessment of AI preclinical studies in diagnostic endoscopy
Artificial intelligence (AI) holds significant potential for enhancing quality of gastrointestinal (GI) endoscopy, but the adoption of AI in clinical practice is hampered by the lack of rigorous standardisation and development methodology ensuring generalisability. The aim of the Quality Assessment of pre-clinical AI studies in Diagnostic Endoscopy (QUAIDE) Explanation and Checklist was to develop recommendations for standardised design and reporting of preclinical AI studies in GI endoscopy. The recommendations were developed based on a formal consensus approach with an international multidisciplinary panel of 32 experts among endoscopists and computer scientists. The Delphi methodology was employed to achieve consensus on statements, with a predetermined threshold of 80% agreement. A maximum three rounds of voting were permitted. Consensus was reached on 18 key recommendations, covering 6 key domains: data acquisition and annotation (6 statements), outcome reporting (3 statements), experimental setup and algorithm architecture (4 statements) and result presentation and interpretation (5 statements). QUAIDE provides recommendations on how to properly design (1. Methods, statements 1–14), present results (2. Results, statements 15–16) and integrate and interpret the obtained results (3. Discussion, statements 17–18). The QUAIDE framework offers practical guidance for authors, readers, editors and reviewers involved in AI preclinical studies in GI endoscopy, aiming at improving design and reporting, thereby promoting research standardisation and accelerating the translation of AI innovations into clinical practice.
QUAIDE - Quality assessment of AI preclinical studies in diagnostic endoscopy
Artificial intelligence (AI) holds significant potential for enhancing quality of gastrointestinal (GI) endoscopy, but the adoption of AI in clinical practice is hampered by the lack of rigorous standardisation and development methodology ensuring generalisability. The aim of the Quality Assessment of pre-clinical AI studies in Diagnostic Endoscopy (QUAIDE) Explanation and Checklist was to develop recommendations for standardised design and reporting of preclinical AI studies in GI endoscopy. The recommendations were developed based on a formal consensus approach with an international multidisciplinary panel of 32 experts among endoscopists and computer scientists. The Delphi methodology was employed to achieve consensus on statements, with a predetermined threshold of 80% agreement. A maximum three rounds of voting were permitted. Consensus was reached on 18 key recommendations, covering 6 key domains: data acquisition and annotation (6 statements), outcome reporting (3 statements), experimental setup and algorithm architecture (4 statements) and result presentation and interpretation (5 statements). QUAIDE provides recommendations on how to properly design (1. Methods, statements 1–14), present results (2. Results, statements 15–16) and integrate and interpret the obtained results (3. Discussion, statements 17–18). The QUAIDE framework offers practical guidance for authors, readers, editors and reviewers involved in AI preclinical studies in GI endoscopy, aiming at improving design and reporting, thereby promoting research standardisation and accelerating the translation of AI innovations into clinical practice.